Therapeutic implications of the pathophysiology of COPD
- PMID: 20190332
- DOI: 10.1183/09031936.00120609
Therapeutic implications of the pathophysiology of COPD
Abstract
This review examines 18 studies published > or =30 yrs ago. They show that the earliest manifestation of chronic obstructive pulmonary disease (COPD) is an increase in residual volume suggesting that the natural history of COPD is a progressive increase in gas trapping with a decreasing vital capacity (VC). The reduction in VC forces the forced expiratory volume in 1 s to decline with it. This is aggravated by rapid shallow breathing leading to dynamic hyperinflation. The earlier studies show that this is energetically opposite to a minimal work or force pattern and is responsible for dyspnoea and exercise limitation. This information, available for >30 yrs leads to three virtually untested hypotheses: 1) training patients to breathe slowly and deeply transiently during exercise should decrease the work of breathing, dynamic hyperinflation and improve exercise performance; 2) rapid shallow breathing is caused by alveolar and bronchial inflammation that stimulates non-myelinated vagal C-fibre afferents, which are known to cause this breathing pattern; and 3) if so, therapeutic efforts to block these afferents might restore a slow-deep pattern and be beneficial, particularly in COPD exacerbations.
Comment in
-
Panic attacks in COPD and the somato-psycho-somatic feedback.Eur Respir J. 2010 Aug;36(2):457; author reply 457-8. doi: 10.1183/09031936.00045310. Eur Respir J. 2010. PMID: 20675786 No abstract available.
Similar articles
-
[Physiopathology of acute respiratory failure in COPD and asthma].Minerva Anestesiol. 2001 Apr;67(4):198-205. Minerva Anestesiol. 2001. PMID: 11376510 Review. Italian.
-
[Evaluation of dynamic hyperinflation parameters and exercise capacity at maximal exercise in patients with COPD].Tuberk Toraks. 2005;53(4):340-6. Tuberk Toraks. 2005. PMID: 16456732 Turkish.
-
Does mechanical injury of the peripheral airways play a role in the genesis of COPD in smokers?COPD. 2004 Apr;1(1):85-92. doi: 10.1081/COPD-120028700. COPD. 2004. PMID: 16997741
-
Breathing pattern and chest wall volumes during exercise in patients with cystic fibrosis, pulmonary fibrosis and COPD before and after lung transplantation.Thorax. 2010 Sep;65(9):808-14. doi: 10.1136/thx.2009.131409. Thorax. 2010. PMID: 20805177
-
Dyspnea and activity limitation in COPD: mechanical factors.COPD. 2007 Sep;4(3):225-36. doi: 10.1080/15412550701480455. COPD. 2007. PMID: 17729066 Review.
Cited by
-
Inhaled β-agonist does not modify sympathetic activity in patients with COPD.BMC Pulm Med. 2015 Apr 30;15:46. doi: 10.1186/s12890-015-0054-7. BMC Pulm Med. 2015. PMID: 25924990 Free PMC article. Clinical Trial.
-
Update on the roles of distal airways in COPD.Eur Respir Rev. 2011 Mar;20(119):7-22. doi: 10.1183/09059180.10010610. Eur Respir Rev. 2011. PMID: 21357888 Free PMC article. Review.
-
The continuum of physiological impairment during treadmill walking in patients with mild-to-moderate COPD: patient characterization phase of a randomized clinical trial.PLoS One. 2014 May 1;9(5):e96574. doi: 10.1371/journal.pone.0096574. eCollection 2014. PLoS One. 2014. PMID: 24788342 Free PMC article. Clinical Trial.
-
Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research - a consensus document from six scientific societies.Int J Chron Obstruct Pulmon Dis. 2017 Aug 29;12:2593-2610. doi: 10.2147/COPD.S132236. eCollection 2017. Int J Chron Obstruct Pulmon Dis. 2017. PMID: 28919728 Free PMC article. Review.
-
MicroRNAs as promising drug delivery target to ameliorate chronic obstructive pulmonary disease using nano-carriers: a comprehensive review.Mol Cell Biochem. 2025 Mar;480(3):1431-1448. doi: 10.1007/s11010-024-05110-0. Epub 2024 Sep 10. Mol Cell Biochem. 2025. PMID: 39254870 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical